| P50 | author | Steven G Gray | Q38325510 |
| | Stephen P. Finn | Q40115968 |
| | Martin Barr | Q42762920 |
| P2093 | author name string | Kenneth J O'Byrne | |
| | Lauren MacDonagh | |
| | Sinead Cuffe | |
| P2860 | cites work | Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 | Q24655144 |
| | miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation | Q24655473 |
| | The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes | Q28241840 |
| | Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart | Q28279009 |
| | MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers | Q37274389 |
| | EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers | Q39430432 |
| P433 | issue | 2 | |
| P921 | main subject | microRNA | Q310899 |
| | lung cancer | Q47912 |
| P304 | page(s) | 160-169 | |
| P577 | publication date | 2014-12-23 | |
| P1433 | published in | Cancer Treatment Reviews | Q1955762 |
| P1476 | title | The emerging role of microRNAs in resistance to lung cancer treatments | |
| P478 | volume | 41 | |